Biospecimen Repository Will Enhance Research Capabilities

Carol J. Farhangfar, PhD, MBA
Assistant Vice President of Carolinas HealthCare System’s Tissue Procurement & Translational Research at Levine Cancer Institute

Carolinas HealthCare System has created a BioSpecimen Repository that will be used to analyze blood, tissue, DNA and other samples drawn from patients across the System in an effort to understand how to target and more effectively treat a broad range of diseases.  

The BioSpecimen Repository opened in May at Charlotte Medical Clinic-Mint Hill, to ensure a centralized space and protected environment for the storage of tissues. The space includes:

  • A large freezer that can hold up to 38,000 samples each
  • Liquid nitrogen tanks that hold up to 60,000 samples
  • A backup generator
  • And a biosafety cabinet to ensure the highest level of protection for all samples

“The BioSpecimen Repository will greatly enhance the capabilities of the System’s research team, through providing superior capabilities in clinical and translational research, said Carol J. Farhangfar, PhD, MBA, assistant vice president of Carolinas HealthCare System’s Tissue Procurement & Translational Research at Levine Cancer Institute.  “My hope is that, through the creation of this repository, Carolinas HealthCare System will begin to be nationally recognized as a clinical service provider that is at the forefront of advancing the field of personalized medicine.”

Biopecimens are removed from patients during a biopsy, surgery or other procedure and are then stored for research. Learning more about the biology of a cancer patient’s tumor, for example, can provide important insight into how best to treat the tumor. While samples taken from cancer patients will be kept and analyzed at the repository, tissues from patients affected by a variety of diseases or diagnoses will be studied as well. Additionally, the repository will establish a state-of-the-art information system to track biospecimen collection data.

Learn more about the System’s ongoing research and clinical trials